Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-03-12Clinical Trial Update: Study of Diagnostic Performance of [18F]CTT1057 in BCR [Phase 3]
Novartis completed a Phase 3 trial evaluating the diagnostic performance of the radiopharmaceutical [18F]CTT1057 in detecting biochemical re…
-
CLINICAL_TRIALS trial_result · 2025-03-12Clinical Trial Update: [18F]Florastamin PET/CT Imaging Examination in Patients With Suspected Recurrent or Metastatic Prostate Cancer [Phase 3]
This Phase 3 trial evaluates the PET imaging agent [18F]Florastamin for detecting suspected recurrent or metastatic prostate cancer; FutureC…
-
CLINICAL_TRIALS trial_result · 2025-03-10Clinical Trial Update: A Study of Ladiratuzumab Vedotin in Advanced Solid Tumors [Phase 2]
Phase 2 trial of ladiratuzumab vedotin in multiple advanced solid tumors was terminated, with results posted in March 2025.
-
CLINICAL_TRIALS trial_result · 2025-03-10Clinical Trial Update: ProA Study: ProActive Management Model in Metastatic Hormone Sensitive Prostate Cancer (mHSPC) Treated by Apalutamide
Clinical trial update for the ProA Study evaluating an active management model in metastatic hormone-sensitive prostate cancer treated with …
-
CLINICAL_TRIALS trial_result · 2025-03-07Clinical Trial Update: Safety, Tolerability and Pharmacokinetics (PK) Evaluation of BZ371A, Topically Administered [Phase 1]
Phase 1 clinical trial assessing safety, tolerability, and pharmacokinetics of BZ371A applied topically for erectile dysfunction, including …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-03-07Clinical Trial Update: Protons Vs. Photons for High-risk Prostate Cancer [NA]
An ongoing trial compares proton therapy versus photon therapy for high-risk prostate cancer, focusing on radiotherapy side effects; the stu…
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer [Phase 2, Phase 3]
The document provides an update on a Phase 2/Phase 3 trial evaluating abiraterone acetate plus prednisone with or without abemaciclib (LY283…
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: MGD019 DART® Protein in Unresectable/Metastatic Cancer [Phase 1]
MGD019, a DART protein from MacroGenics, is being studied in a Phase 1 trial for unresectable/metastatic cancers, including non-small cell l…
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: Effectiveness of Cryotherapy Study for Prostate Cancer [NA]
This clinical trial update reports on the completed study evaluating the effectiveness of cryotherapy for prostate cancer.
-
CLINICAL_TRIALS trial_result · 2025-03-06Clinical Trial Update: PRospective REgistry of Advanced Stage CancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine
A completed multicancer registry study (PREFER) assessing the prevalence of actionable biomarkers and driver mutations across advanced cance…
-
CLINICAL_TRIALS trial_result · 2025-03-05Clinical Trial Update: Epidiolex (CBD) in Patients With Biochemically Recurrent Prostate Cancer [Phase 1]
Phase 1 trial evaluating Epidiolex (cannabidiol) in biochemically recurrent prostate cancer has completed with results posted. The study inv…
-
CLINICAL_TRIALS trial_result · 2025-03-04Clinical Trial Update: Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-tumor Activity of Ascending Doses of ARN 509 in Combination With Abiraterone Acetate [Phase 1]
Phase 1 study to evaluate safety, tolerability, pharmacokinetics, and preliminary anti-tumor activity of escalating doses of ARN-509 (apalut…
-
CLINICAL_TRIALS trial_result · 2025-03-04Clinical Trial Update: A Study of JNJ-80038114 in Participants With Advanced Stage Prostate Cancer [Phase 1]
This Phase 1 study of JNJ-80038114 in participants with advanced-stage prostate cancer has completed.
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: Oral EPI-7386 in Patients with Castration-Resistant Prostate Cancer [Phase 1]
The Phase 1 trial of oral EPI-7386 in patients with castration-resistant prostate cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: Effectiveness of Localized Prostate Cancer Treatments
Clinical trial update assessing the effectiveness of localized treatments for prostate cancer (NCT01492751). The study is currently not recr…
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: EPI-7386 in Combination with Enzalutamide Compared with Enzalutamide Alone in Subjects with MCRPC [Phase 1, Phase 2]
A Phase 1/2 trial evaluating EPI-7386 in combination with enzalutamide versus enzalutamide alone in metastatic castration-resistant prostate…
-
CLINICAL_TRIALS trial_result · 2025-02-28Clinical Trial Update: PSMA-PET/MRI Unfavorable-Risk Target Volume Pilot Study [Phase 2]
The Phase 2 PSMA-PET/MRI Unfavorable-Risk Target Volume Pilot Study for prostate cancer was terminated, and results were posted on 2025-02-2…
-
CLINICAL_TRIALS trial_result · 2025-02-26Clinical Trial Update: Imaging Study to Investigate Safety and Diagnostic Performance of 18F rhPSMA 7.3 PET Ligand in Suspected Prostate Cancer Recurrence [Phase 3]
Phase 3 imaging trial evaluating the safety and diagnostic performance of the 18F rhPSMA-7.3 PET ligand in suspected prostate cancer recurre…
-
CLINICAL_TRIALS trial_result · 2025-02-26Clinical Trial Update: Imaging Study to Investigate the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) in Newly Diagnosed Prostate Cancer. [Phase 3]
Phase 3 imaging trial evaluating rhPSMA 7.3 (18F) for safety and diagnostic performance in newly diagnosed prostate cancer has completed and…
-
CLINICAL_TRIALS trial_result · 2025-02-26Clinical Trial Update: Weight Management Aimed to Reduce Risk and Improve Outcomes From Radical Prostatectomy [NA]
This clinical trial evaluated a weight management intervention aimed at reducing risk and improving outcomes after radical prostatectomy in …
-
CLINICAL_TRIALS trial_result · 2025-02-26Clinical Trial Update: Preliminary Evaluation of Uptake of [68Ga]P16-093 in Metastatic Prostate and Renal Cancer [Phase 1]
Phase 1 trial completed evaluating uptake of the radiotracer [68Ga]P16-093 in metastatic prostate cancer and metastatic renal cell carcinoma…
-
CLINICAL_TRIALS trial_result · 2025-02-26Clinical Trial Update: The BurnAlong Pilot Study for Adolescent and Young Adult Cancer Survivors [NA]
Completed update for the BurnAlong Pilot Study evaluating a program for adolescent and young adult cancer survivors. The study spans multipl…
-
CLINICAL_TRIALS trial_result · 2025-02-26Clinical Trial Update: Rectal Spacer Hydrogel Before Radiation Therapy in Reducing Radiation Dose to the Rectum in Patients With Prostate Cancer [NA]
This update reports that a clinical trial evaluating a rectal spacer hydrogel to reduce radiation exposure to the rectum during prostate can…
-
CLINICAL_TRIALS trial_result · 2025-02-26Clinical Trial Update: IIT2020-20-SHIRAZIP-WALK: Nature Walks [NA]
The IIT2020-20-SHIRAZIP-WALK trial sponsored by Cedars-Sinai Medical Center has completed, studying breast cancer and several hematologic ma…
-
CLINICAL_TRIALS trial_result · 2025-02-25Clinical Trial Update: The Efficacy of Mapping for Cognitive Prostate Biopsy [NA]
A Marmara University-sponsored clinical trial evaluating the efficacy of mapping for cognitive prostate biopsy in prostate cancer has comple…